Linking Performance and Compliance: How Part D Quality Measures Relate to Plan Performance

Similar documents
MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

Part II: Medicare Part C and Part D

2018 Medicare Part D Transition Policy

Part D Performance Audits - Formulary Administration

Medicare 2017 Part C & D Star Rating Technical Notes

Submitted via Federal e-rule making Portal: April 5, 2019

MMP (CalMediconnect) Community Health Group. and. First Tier, Downstream & Related Entity

Transition Guidance for Non-Special Needs Enrollees in MA Special Needs Plans Under the Disproportionate Share Policy

CMS Proposed Rulemaking For The Medicare Advantage And Medicare Prescription Drug Programs

BlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals

Case-Mix Coefficients for MA & PDP CAHPS

Medicare Part D Compliance & Oversight Overview

Annual Notice of Changes for 2019

Annual Notice of Changes for 2019

MEDICARE PART D PRESCRIPTION DRUG BENEFIT

Presenters. Sara Kay Wheeler. Kirk Dobbins Peachtree St., NE Atlanta, GA Phone: (404)

Values Accountability Integrity Service Excellence Innovation Collaboration

Medicare Parts C & D General Compliance Training

Medicare Advantage and Part D Contract Compliance & Oversight Overview

Introductory Guide to Medicare Part C and D

You have from October 15 until December 7 to make changes to your Medicare coverage for next year.

2017 Medicare Advantage and Prescription Drug Overview. Module 2

Data-Driven Drug Coverage. Harnessing Information for a Better Medicare Prescription Drug Program. w w w.americanprogress.org

Introduction to Medicare Parts C and D

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

2017 National Training Program

Annual Notice of Changes for 2019

Answers to Frequently Asked Questions

SecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals

Appeals and Grievances: What to Do if You Have Complaints About Your Part D Prescription Drug Benefits

Convenient Access to Retail Pharmacies - Analysis on Preferred Cost-Sharing Pharmacy Networks

kaiser medicaid and the uninsured commission on O L I C Y R I E F April 2012

FDR Compliance Guide. Paramount

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for October 2008

ADVANTAGE Medicare Plan Choice Plus (HMO) offered by CommunityCare Government Programs. Annual Notice of Changes for 2018

Driving Member Engagement and Improving Star Ratings With Rewards Programs

The State of Medicare Advantage 2017

Medicare Advantage Part D Pharmacy Policy

2016 Medicaid Managed Care Final Rule 1 Summary

MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers

Medicare Advantage Value-Based Insurance Design Model Test. Responses to Stakeholder Inquiries. Last updated: November 10, 2015

Choosing Between Traditional Medicare and Medicare Advantage

CMS Part D UPDATES. Kim Brandt Director, Program Integrity Centers for Medicare & Medicaid Services

Re: Comments on Draft 2017 Letter to Issuers in the Federally-facilitated Marketplaces

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

2018 Medicare Advantage and Part D Rate Announcement and Call Letter, and Request

March 3, VIA Electronic Filing:

summary of benefits Blue Shield of California Medicare Rx Plan (PDP)

All Medicare Advantage Products with Part D Benefits

Annual Notice of Changes for 2018

2018 PRODUCT TRAINING

Annual Notice of Changes for 2018

The Medicare Advantage and Part D Programs

2019 Transition Policy

Summary of Benefits. January 1 December 31, 2011

Medicare Updates. Illinois Department on Aging Senior Health Insurance Program (SHIP)

POLICY / PROCEDURE No. PH-917 MMM-PHA-POL E. Transition Process

Health Care Compliance Association: Pre-Conference Medicare Part D 101 February 22, 2009

Medicare Transition POLICY AND PROCEDURES

Issue brief: Medicaid managed care final rule

Annual Notice of Changes for 2018

Health Care Compliance Association: Pre-Conference

Farm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017

2019 Transition Policy and Procedure

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

(PDP) 2014 Summary of benefits for our Medicare prescription drug plans (Enhanced and Standard)

Chapter 9: What to do if you have a problem or complaint (coverage decisions, appeals, complaints)

2015 National Training Program. Lessons. Lesson 1 Legislative Updates. Module 4. Current Topics. July 2015

Modernizing Louisiana s Medicaid

Medicare Advantage and Other Medicare Plans 1

ANNUAL NOTICE OF CHANGES FOR 2019

CMS Releases Proposed Rule on Medicare Advantage and Medicare Prescription Drug Plan MLR Requirements. Jacinta L. Alves

SHARP HEALTH PLAN MEDICARE ADVANTAGE POLICY AND PROCEDURE Product Line (check all that apply):

Your Prescription Drug Plan Renewal Materials

Required CMS Contract Clauses Revised 8/28/14 CMS MCM Guidance Chapter 21

ANNUAL NOTICE OF CHANGES FOR 2018

YOUR DRUG(S) IS NOT ON OUR LIST OF COVERED DRUGS (FORMULARY) OR IS SUBJECT TO CERTAIN LIMITS

Annual Notice of Changes for 2018

TRANSITION POLICY. Members Health Insurance Company

ANNUAL NOTICE OF CHANGES FOR 2018

Annual Notice of Changes for 2019

Summary of Benefits. Aetna Medicare Rx Costco Plus Plan (PDP) S5810. California. January 1, 2010 to December 31, 2010

American Bar Association. Technical Session Between the Centers for Medicare and Medicaid Services and the Joint Committee on Employee Benefits

FINDINGS FROM THE KAISER/HEWITT 2006 SURVEY ON RETIREE HEALTH BENEFITS

The Medicare Advantage program: Status report

Agency Information Collection Activities: Proposed Collection; Comment Request

Medicare Advantage (Part C) Review

Medicare Part D Transition Policy

Understanding Pay For Performance and DIR Impact to Pharmacy Reimbursement

Annual Notice of Changes for 2018

FDR. Compliance Guide

Frequently Asked Questions. PBP Data Entry/Cost Sharing

Frequently Asked Questions (FAQs) for First Tier, Downstream and Related Entities (FDRs)

You have from October 15 until December 7 to make changes to your Medicare coverage for next year.

Coverage Determinations, Appeals and Grievances

Commitment to Compliance

2017 Medicare Basics. Module 1

Annual Notice of Changes for 2018

Transcription:

Linking Performance and Compliance: How Part D Quality Measures Relate to Plan Performance Medicare Rx Part D Compliance Conf. Monday, December 8, 2008 9:45 a.m. 10:45 a.m. Cynthia Tudor, PhD Director of Medicare Drug Benefit and C&D Data Group Center for Drug and Health Plan Choice Overview 1. Collection of Program Data 2. Reporting Measures and Performance Metrics 3. Compliance and Monitoring 4. Moving Forward 2

Why has CMS decided to Implement Data Collection? To improve transparency of the Part C & D programs. To provide cost, quality, and performance information to consumers. To ensure appropriate oversight consistent with our responsibilities. 3 Purpose of Data Collection The goal is to expand and improve the set of measures for Part C & D. Measures should accomplish one or more of the following: Provide measures for consumer quality and performance of Medicare Advantage and Prescription Drug Plans. Indicate overall program performance and provide key information for policy-making. Improve CMS information on the extent of compliance. 4

Part D Regulatory Authority 42 CFR 423.503(d): CMS oversees a Part D plan sponsor s continued compliance with the requirements for a Part D plan sponsor. If a sponsor no longer meets those requirements, CMS terminates the contract in accordance with 423.509. In addition, 42 CFR 423.505 outline a number of contract requirements that specify disclosure of information requirements on the part of Part D sponsors and the right to inspection by CMS. These clearly outline CMS ability to collect information for program monitoring with our requirements. 5 Part C Regulatory Authority 42 CFR 422.502(d): CMS oversees an MA organization s continued compliance with the requirements for an MA organization. If an MA organization no longer meets those requirements, CMS terminates the contract in accordance with 422.510. Additionally, 42 CFR 422.504 outlines similar contract provisions on the disclosure of information to CMS and right to inspection by CMS and OIG. 6

Part D Reporting Measures and Performance Metrics 7 Medicare Part D Plan Ratings Allow Medicare beneficiaries to compare Plans cost, quality, and performance. Overall Parts C and D composite scores for quick evaluations of plans across broad areas. Half-stars to further differentiate plans and sponsors. Reorganized performance measures and improved website language and formats. Expanded measures include CMS first public analysis of quality in prescription drug coverage. New feature - print on demand of plan and sponsor ratings available by state or contract. 8

CY2009 Medicare Part D Plan Ratings Plan Ratings were released on the Medicare Prescription Drug Plan Finder on November 13, 2008. Rating based on adjusted averages of the individual measures. Consistency in good performance will receive higher ratings. Part D Plan Ratings will include: One composite summary score (with stars). Four domains (with stars). 19 measures (with stars and rates, numbers, or percentages). 9 2009 Summary Score Distributions 45% 40% 35% 30% 25% 20% 15% PDP MA-PD 10% 5% 0% 1 star 2 stars 3 stars 4 stars 5 stars 10

New CY2009 Part D Domains CY2008 3 domains Drug Plan Consumer Service Using Your Plan to get Your Prescriptions Filled Drug Pricing Information CY2009 4 domains Drug Plan Customer Service Member complaints and staying with drug plan Member experience with drug plan Drug pricing and patient safety 11 Drug Plan Customer Service Measures 70% 60% 50% 40% 30% PDP MA-PD 20% 10% 0% 1 star 2 stars 3 stars 4 stars 5 stars 12

Member Complaints and Staying with Drug Plan 40% 35% 30% 25% 20% 15% PDP MA-PD 10% 5% 0% 1 star 2 stars 3 stars 4 stars 5 stars 13 Member Satisfaction with Drug Plan 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% 1 star 2 stars 3 stars 4 stars 5 stars PDP MA-PD 14

Drug Pricing Information and Patient Safety 60% 50% 40% 30% 20% PDP MA-PD 10% 0% 1 star 2 stars 3 stars 4 stars 5 stars 15 New CY2009 Medicare Part D Plan Ratings Measures All Other Complaints about the Drug Plan Members Who Stay with Their Current Drug Plan from One Year to the Next Drug Plan s Prices on Medicare s Website Are Similar to the Prices Members Pay at the Pharmacy Drug Plan s Members 65 and Older Who Received Prescriptions for Certain Drugs with a High Risk of Side Effects 16

Why Reporting Requirements? CMS use of plan-reported data Program-descriptive Evaluate differences between plan-types Integrate with evaluation of other data sources 1-800 Medicare complaints data Prescription Drug Event data IRE data Monitoring studies (e.g., Call center) Audits Unavailable through other sources or collection efforts More timely than other means of collecting this information 17 Part D Reporting Requirements Current 2008 requirements to remain in effect for CY2009 (currently collecting data in 15 categories). Proposed changes for CY2010: Streamlining of existing sections Adding new sections associated with MIPPA LTC rebate changes Potential other new sections: Fraud & Abuse Compliance Programs and Enrollment CY2010 Reporting Requirements comment period for the Paperwork Reduction Act (PRA) projected for January 2009. Auditing in 2010. 18

Part D Reporting Requirements Categories Retail, Home Infusion, and LTC Pharmacy Access Access to Extended Day Supplies at Retail Pharmacies Vaccines Medication Therapy Management Programs Generic Drug Utilization Grievances Pharmacy & Therapeutics (P&T) Committees/Part D Activities Transition 19 Part D Reporting Requirements Categories Continued Exceptions Appeals Overpayment Pharmaceutical Manufacturer Rebates, Discounts, and Other Price Concessions Long-Term Care (LTC) Rebates Licensure and Solvency, Business Transactions and Financial Requirements Drug Benefit Analyses 20

Part D Reporting Requirements Technical Specifications provide additional guidance for Plans More detailed definitions Lists of validation edits and QA checks CMS use of plan-reported data Program-descriptive Evaluate differences between MA-PDs and PDPs Integrate with evaluation of other data sources 1-800 Medicare complaints data Prescription Drug Event data IRE data 21 Example: 2007 Pt. D Grievances Type Total Grievances Rate / 1,000 Enrollees Percentage MA-PD Aggregate 823,833 113.9 81.4% PDP Aggregate 187,560 11.1 18.5% Employer Direct Aggregate 942 7.7 0.1% Total 1,012,335 22

Example: 2007 Pt. D GDR Type Q1 Q2 Q3 Q4 YTD PDP Aggregate 60.1% 62.1% 63.4% 64.9% 62.7% MA-PD Aggregate 65.6% 68.3% 68.1% 70.7% 68.1% Combined 61.5% 63.7% 64.7% 66.3% 64.1% 23 Part C Reporting Measures and Performance Metrics 24

Medicare Part C Plan Ratings Changes for CY 2009 Summary score that provides an overall rating of all of the quality and performance data available 6 additional measures reported Language refined based on consumer testing Print on demand of plan ratings available by state or contract Limited SNP quality information available at the plan level 25 2009 Summary Score Distributions 80 70 60 50 40 30 20 10 0 1 star 1.5 stars 2 stars 2.5 stars 3 stars 3.5 stars 4 stars 4.5 stars 5 stars 26

Part C Domains for Plan Ratings The domains remain the same as CY 2008; however, domain titles have been revised as a result of consumer feedback Ratings of Health Plan Responsiveness and Care (6 measures) Managing Chronic (Long-Lasting) Conditions (12 measures) Getting Timely Care From Doctors and Specialists (4 measures) Staying Healthy: Screenings, Tests and Vaccines (12 measures) How Well and Quickly Health Plans Handled Appeals (2 measures) 27 Ratings of Health Plan Responsiveness and Care 160 140 120 100 80 60 40 20 0 1 star 2 stars 3 stars 4 stars 5 stars 28

Managing Chronic (Long-Lasting) Conditions 160 140 120 100 80 60 40 20 0 1 star 2 stars 3 stars 4 stars 5 stars 29 Getting Timely Care from Doctors and Specialists 180 160 140 120 100 80 60 40 20 0 1 star 2 stars 3 stars 4 stars 5 stars 30

Staying Healthy: Screenings, Tests and Vaccines 180 160 140 120 100 80 60 40 20 0 1 star 2 stars 3 stars 4 stars 5 stars 31 How Well and Quickly Health Plans Handled Appeals 70 60 50 40 30 20 10 0 1 star 2 stars 3 stars 4 stars 5 stars 32

New CY2009 Medicare Part C Plan Ratings Measures Improving or Maintaining Physical Health Improving or Maintaining Mental Health Osteoporosis Testing Monitoring Physical Activity Improving Bladder Control Reducing the Risk of Falling 33 Part C Reporting Requirements CMS has received many inquiries about operations, costs, availability of services, beneficiary use of available services, patient safety, grievance rates, and other factors pertaining to the performance of MAOs under Part C. To date, CMS has not been able to address many of these inquiries because of an absence of data. Initiating data collection in these and other areas to improve its performance monitoring of MAOs. 34

Part C Reporting Requirements Public Notice PRA notice published on October 3 with 30-day comment period OMB approval anticipated in late 2008 MAOs to collect these data beginning on January 1, 2009 Reporting will vary depending on the plan type and measure Some measures will be reported annually, while others will be reported quarterly or semi-annually. All measures included in these technical specifications are subject to audit by 2010 35 Examples of Part C Reporting Categories Beneficiary Utilization To determine if Part A & B rebates are being used to increase access to care and/or to improve care Procedures Plans with lower than expected rates of these procedures may have barriers to care. CMS will look for outliers in rates of semi-elective procedures Serious Reportable Adverse Events Plans with any of these events should take steps to get at root causes and implement procedures to guard against the events from happening again. CMS will compare MA organizations on these measures in order to identify outliers. CMS will then attempt to determine the reasons for unusually high or low rates on these measures 36

Examples of Part C Reporting Categories Provider Network Adequacy and Stability To date CMS does not have mechanism for assuring continued network adequacy Grievances Any complaint or dispute, other than one involving an organization determination, expressing dissatisfaction with any aspect of the operations, activities, or behavior of an MA organization, regardless of whether remedial action is requested. MAOs are required to track and maintain records on all grievances received both orally and in writing Marketing Measures (Commission Structure, Agent Oversight, Training/Testing of Agents) 37 Other Changes Changes due to statutory and regulatory revisions that have occurred after June 26, 2008. Special Needs Plans (SNPs) Care Management. Section 164 of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) requires all SNPs to have an evidenced-based model of care with appropriate networks of providers and specialists. Several measures, including agent commission structure, training and testing of agents, and plan oversight of agents, were revised as a result of MIPPA and the finalization of our regulation entitled, Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Program (CMS 4131-F) 38

Compliance and Monitoring 39 Translating Performance Measurement and Monitoring into Compliance Compliance Strategy Take deadlines seriously Look for outliers Take note of single instances of problems, but emphasize patterns of non-compliance Put aside the battering ram (CAP, enrollment sanctions) when a soft nudge (notice of noncompliance) is sufficient But don t hesitate to take significant action where warranted Consistent application of standard and choice of compliance action across all contracts 40

Compliance Tools Executive Conference Call/Meeting Notice of Non-Compliance May include request for business plan Warning Letter May include request for business plan Various Suppressions and Exclusions: MPDPF suppression Medicare & You Handbook exclusion On-line enrollment center exclusion Fewer formulary update windows No reassignments/auto-enrollees Request for Corrective Action Plan (CAP) New Applications/SAE Denials Audit Selection Enforcement and Termination 41 Examples of Compliance Action from Data Analysis and Monitoring Low Income Subsidy Match Rate Failure to successfully submit data Failure to exceed the 95% match rate Number and type of prior compliance actions on this topic drive the next action Reporting Requirements Missed deadlines and non-submissions Data outlier, e.g., extreme number of grievances We issued outlier warning notices and required sponsors to analyze their performance and report back 42

In-depth Example: Grievance Data from Reporting Requirements CMS calculated the number of grievances per 1,000 enrollees for each sponsor Source: 2006 grievance data from Part D Reporting Requirements Sponsors with a grievance ratio among the top 5% were issued outlier warning notices Required to report back to CMS What were the primary underlying enrollee concerns that prompted grievances filed with your plans under this contract? What are your current procedures for handling grievances that you have received, and do these procedures differ in any way from those you had in place during 2006? What actions have you taken, or are you are planning to take, to improve your grievance rate and prevent your organization from being an outlier in the future? How do these actions relate to the underlying issues that prompted the grievances in the first instance? 43 In-depth Example: Grievance Data from Reporting Requirements, cont. After their self-analysis many sponsors reported they had uncovered data anomalies and process problems Sponsors found it very useful feedback and have reported process improvements Led sponsors to refine their processes for identifying, tracking, and reporting grievances and to address underlying problems that attributed to the grievances in the first instance CMS will repeat same analysis for 2007 data to assess if these sponsors have made improvements and to identify current outliers Sponsors that are outliers two years in a row will receive escalated notice or will be targeted for audit 44

Additional Examples Call center monitoring Inadequate call center hours We identified when call centers were not open during all expected timeframes Failure to meet call center standards CTM Cases Failure to close 95% of immediate need cases timely Formulary Submissions Missed deadlines or other poor performance Performance Metrics (star ratings) Low ratings multiple years in a row in the same category 45 Compliance Actions Tracker CMS maintains history of compliance notifications in a compliance tracker database This allows for: Longitudinal analysis of account performance to identify trends Holistic compliance profile for each account Alert AM s of prior plan compliance actions and inform CMS of related issues An organization s overall compliance history may be used as: Determining frequency of monitoring activities Factor in approving future contract applications Considering appropriateness of enforcement referral 46

Example: Jan 2007 June 2008 Data and Ad Hoc CAPs and Warning Letters Basis for Action Data-Driven Ad hoc Combined CAP 0 72 72 Warning Letter 377 28 405 47 Moving Forward 48

Next Steps Continue to ensure accurate data is provided for C&D Reporting Requirements Attestation, followed by auditing Use reported data to ensure compliance 49 Questions? 50